Personalized management of essential thrombocythemia-application of recent evidence to clinical practice
about
Recent advances in understanding myelofibrosis and essential thrombocythemiaPolycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and managementCoronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: the missing piece in the puzzle of their increased cardiovascular risk?Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case.Thrombotic risk assessment in 185 WHO-defined essential thrombocythemia patients: single center experience.Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera.Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.Target hematologic values in the management of essential thrombocythemia and polycythemia vera.Antiplatelet therapy in the management of myeloproliferative neoplasms.Advances and challenges in the management of essential thrombocythemia.Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service.Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count.Predictors of survival and cause of death in patients with essential thrombocythemia.External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients.
P2860
Q26748543-3FCBCDCC-92C1-4FB3-B9A9-6693EE57E554Q26851894-B180A4F1-C22D-4573-98FF-0A9057FC95A3Q33359341-67A9A487-1C9B-463A-8151-1067BBC3EAEEQ34037065-09863A3F-9B46-4E23-8A76-17AE2F946F28Q35957808-7964747F-AB3C-4BA7-93C1-FE12037184F7Q36452870-F5C85198-8B03-4952-971A-2183DEAFDD66Q37672905-755EC85A-9135-4249-AB0C-C36917C7217FQ38187675-6F25D831-2971-497D-AC6D-EB8E0702EA98Q38210664-1F27E277-EEF0-4C80-A2E7-14E7D71464E3Q38239616-CA76E08C-3075-42EB-A7F0-8A0202ECCE1EQ38542093-32213F8D-A202-436A-8817-EB2BF07691FDQ38586505-03007406-C9AD-4CC3-87F0-3D07AEEB06D4Q39124885-E346F41E-5D47-4E2D-AAAE-A726C886BF8AQ42702330-D625DA35-4C0C-43FF-85C1-2F6886B0D03CQ47929354-EB12C901-78F7-4274-95E1-37589CC8BEEBQ52951456-4260F08F-3B3A-4F4B-A6E1-929A436D9BB8Q53076987-3E74D4AB-37C8-44B3-B750-3ACDF236FB0EQ53096238-F88200FF-D2AB-45A9-B32A-AE5D87C912F1
P2860
Personalized management of essential thrombocythemia-application of recent evidence to clinical practice
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Personalized management of ess ...... evidence to clinical practice
@ast
Personalized management of ess ...... evidence to clinical practice
@en
Personalized management of ess ...... evidence to clinical practice
@nl
type
label
Personalized management of ess ...... evidence to clinical practice
@ast
Personalized management of ess ...... evidence to clinical practice
@en
Personalized management of ess ...... evidence to clinical practice
@nl
prefLabel
Personalized management of ess ...... evidence to clinical practice
@ast
Personalized management of ess ...... evidence to clinical practice
@en
Personalized management of ess ...... evidence to clinical practice
@nl
P2860
P3181
P356
P1433
P1476
Personalized management of ess ...... evidence to clinical practice
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/LEU.2013.99
P407
P5008
P577
2013-08-01T00:00:00Z
P5875
P6179
1041277913